Akero Therapeutics, Inc. [AKRO]

Source: 

Company Overview

Akero Therapeutics, Inc. is a clinical-stage company dedicated to developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, including metabolic dysfunction-associated steatohepatitis, or MASH, formerly known as non-alcoholic steatohepatitis, or NASH.